AI-Powered Sepsis Test Shows Promise in Large Clinical Study
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
Read MorePosted by CLP Edit Staff | Oct 1, 2025 | Sepsis |
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
Read MorePosted by CLP Edit Staff | Oct 1, 2025 | Digital Pathology |
Tulsa Medical Lab chooses PathFlow system to unify diagnostic processes across multiple laboratory information systems.
Read MorePosted by CLP Edit Staff | Sep 30, 2025 | Digital Pathology |
The collaboration will deploy FDA-cleared slide scanners across anatomic pathology services to support AI integration and address pathologist shortage.
Read MorePosted by Alyx Arnett | Sep 29, 2025 | Cancer |
First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.
Read MorePosted by Alyx Arnett | Sep 25, 2025 | Lung Cancer |
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read More